Skip to main content
. Author manuscript; available in PMC: 2013 Jul 1.
Published in final edited form as: Gene Ther. 2011 Dec 15;20(1):7–15. doi: 10.1038/gt.2011.205

Figure 3.

Figure 3

Effects of MV on primary melanoma cells. A; Primary cells from freshly explanted melanoma B; Characteristic CPE 48 hours following treatment with MV-GFP by phase contrast (left) and fluorescence (right) microscopy. C; Live/Dead assay 2, 5 and 9 days after treatment of primary cells with MV. Data shown are representative of primary cells from three donors. D; ELISA of supernatant from primary cells treated with MV 72 hours previously.